IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$83.45−1.39 (-1.64%)
Close on Nov 17, 2026Market cap $1.07BP/E 44.6Yield –
IRadimed pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
IRadimed's pe ratio was 48.4× on Nov 11, 2026, against 56.5× a year earlier. Over the last 5 years it ranged from 27.2× to 96.3×, with a median of 39.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 48.4× | −10.6 |
| 2025 | Dec 31, 2025 | 59.0× | +21.3 |
| 2024 | Dec 31, 2024 | 37.7× | +0.9 |
| 2023 | Dec 29, 2023 | 36.8× | +9.6 |
| 2022 | Dec 30, 2022 | 27.2× | −69.1 |
| 2021 | Dec 31, 2021 | 96.3× | +25.0 |
| 2020 | Dec 31, 2020 | 71.3× | +35.8 |
| 2019 | Dec 31, 2019 | 35.4× | −25.7 |
| 2018 | Dec 31, 2018 | 61.1× | −55.4 |
| 2017 | Dec 29, 2017 | 116.5× | +100.5 |
| 2016 | Dec 30, 2016 | 16.1× | −47.6 |
| 2015 | Dec 31, 2015 | 63.7× | +10.0 |
| 2014 | Dec 31, 2014 | 53.8× | – |
See a number that looks wrong?